LIXTE BIOTECHNOLOGY HOLDINGS, INC. - LIXT
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$2.534M
QoQ value delta ($000)
-$426K
(-14.39%)
Implied price effect (QoQ)
-19.91%
Shares
Total shares
807,445
QoQ shares delta
+52,062
(+6.89%)
Total shares held by funds (by quarter)
Market chart (LIXT)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 14 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| SCOTIA CAPITAL INC. | 869 | 283,162 | 0.0% |
| VANGUARD GROUP INC | 294 | 74,944 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 285 | 93,000 | 0.0% |
| Federation des caisses Desjardins du Quebec | 197 | 64,487 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 180 | 58,852 | 0.0% |
| CITADEL ADVISORS LLC | 173 | 56,557 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 151 | 49,479 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 107 | 35,034 | 0.0% |
| Ethos Financial Group, LLC | 76 | 24,808 | 0.01% |
| XTX Topco Ltd | 71 | 23,446 | 0.0% |
| STATE STREET CORP | 53 | 17,396 | 0.0% |
| Atlas Legacy Advisors, LLC | 42 | 13,771 | 0.01% |
| HRT FINANCIAL LP | 34 | 11,346 | 0.0% |
| Tower Research Capital LLC (TRC) | 2 | 973 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 190 | 0.0% |